TerSera Therapeutics
AstraZeneca ends month with two pieces of news
March 31, 2017Medical Communications, Sales and Marketing AstraZeneca, Tagrisso, TerSera Therapeutics, Zoladex
AstraZeneca has ended the month with more positive news on Tagrisso, that had previously been approved in China under its …
AstraZeneca sells off cancer drug to TerSera for $250 million
February 20, 2017Sales and Marketing AstraZeneca, TerSera Therapeutics, Zoladex
AstraZeneca announced that it has sold Zoladex’s (goserelin acetate implant) commercial rights in the US and Canada to TerSera Therapeutics. …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
